A Randomized, Double-Blinded, Active-Controlled, Parallel-Group, Comparative evaluation of Safety and Efficacy of CUQ1720-BOQ-0020G ,CUQ1720 and BOQ-0020G on Healthy Subjects with Spondylitis Difficulties.

Akay Natural Ingredients Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年2月21日

试验速览

暂无简介。

•1.Subjects with known history of spondylitis difficulties
•2.Subject willing to adhere with their routine diet, physical activity, and general lifestyle throughout the study
•3.Must be willing and able to give informed consent and comply with the study procedures.

•1.Subjects with any chronic, acute ailments or with any other diagnosed disorders and under medications.
•2.Subjects having symptoms of viral infection, including COVID-19 infection
•3.Subjects on ongoing treatment for spondylitis with steroids, TNF-alpha inhibitors, etc
•4.Subjects on other therapies such as homeopathy / Ayurveda
•5.Subjects allergic to herbal products or any component of the study product
•6.Known HIV or Hepatitis B positive or any other immuno-compromised state
•7.History of clinically significant comorbidity
•8.Diagnosis of any other clinically significant medical condition which in opinion of investigator may jeopardize subjectâ??s safety and preclude trial participation
•9.Currently participating or having participated in another clinical trial during the last 3 months prior to the beginning of this study
•10.Any additional condition(s) that in the Investigators opinion would warrant exclusion from the study or prevent the subject from completing the study

发起方

Akay Natural Ingredients Pvt Ltd